Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners across 2 art units, indicating separate prosecution channels within the same technology area.
PEEBLES, KATHERINE is the busiest examiner, with 1 pending matter. Counsel can maintain individualized response strategies while coordinating technical positions across the two pending assignments.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PEEBLES, KATHERINE | 1 | 35.6% | +48.0% |
| NOLAN, JASON MICHAEL | 1 | 66.6% | -27.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18847480 | LONG-ACTING SUSTAINED-RELEASE PREPARATION CONTAINING PRAMIPEXOLE AND PREPARATION METHOD THEREFOR | PEEBLES, KATHERINE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18847480 | LONG-ACTING SUSTAINED-RELEASE PREPARATION CONTAINING PRAMIPEXOLE AND PREPARATION METHOD THEREFOR | PEEBLES, KATHERINE | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18847480 | LONG-ACTING SUSTAINED-RELEASE PREPARATION CONTAINING PRAMIPEXOLE AND PREPARATION METHOD THEREFOR | PEEBLES, KATHERINE | 1617 | §103§112Other | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18577644 | LONG-ACTING BREXPIPRAZOLE PREPARATION FOR INJECTION AND PREPARATION METHOD THEREFOR | NOLAN, JASON MICHAEL | 1623 | §112 | Non-Final OA | — | Pending | Jan 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSichuan Kelun Pharmaceutical Research Institute Co. Ltd. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Katherine Peebles has the most, with 1 of Sichuan Kelun Pharmaceutical Research Institute Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
